Search
for

    Sort by

    Research 91–120 of 1000+

    1. Drug repositioning using <i>in silico</i> compound profiling Future Medicinal Chemistry · 2009 · 24 citations
    2. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata Journal of The American Academy of Dermatology · 2019 · 23 citations
    3. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost American Journal of Ophthalmology · 2004 · 23 citations
    4. Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata Dermatology and Therapy · 2021 · 22 citations
    5. Dermatological Manifestations of Stress in Normal and Psychiatric Populations Psychiatric Clinics of North America · 2014 · 22 citations
    6. Contraception and the dermatologist Journal of The American Academy of Dermatology · 2013 · 22 citations
    7. Minoxidil: a comprehensive review Journal of Dermatological Treatment · 2021 · 16 citations
    8. Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case‐series of 64 patients Journal of The European Academy of Dermatology and Venereology · 2020 · 16 citations
    9. Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients Journal of The American Academy of Dermatology · 2020 · 16 citations
    10. Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model The AAPS Journal · 2024 · 15 citations
    11. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost American Journal of Ophthalmology · 2004 · 15 citations
    12. (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production Bioorganic & Medicinal Chemistry Letters · 2007 · 14 citations
    13. Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA Dermatology and therapy · 2022 · 12 citations
    14. Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients Journal of The American Academy of Dermatology · 2021 · 11 citations
    15. Response of alopecia areata of the beard to oral tofacitinib Journal of the American Academy of Dermatology · 2019 · 11 citations
    16. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata Journal of the European Academy of Dermatology and Venereology · 2018 · 11 citations
    17. Chemical pharmacotherapy options for managing adult acne Expert Opinion on Pharmacotherapy · 2017 · 10 citations
    18. Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics International Journal of Dermatology · 2021 · 9 citations
    19. Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series Journal of The American Academy of Dermatology · 2020 · 9 citations
    20. Novel therapies for alopecia areata: The era of rational drug development The Journal of Allergy and Clinical Immunology · 2017 · 9 citations
    21. Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids The Journal of Clinical Endocrinology and Metabolism · 2020 · 8 citations
    22. Hair Transplantation for Men and Women Seminars in Cutaneous Medicine and Surgery · 2006 · 8 citations
    23. Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States Advances in Therapy · 2022 · 7 citations
    24. Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study Journal of the European Academy of Dermatology and Venereology · 2021 · 7 citations
    25. Dermoscopy of an osteonevus of Nanta International Journal of Dermatology · 2013 · 6 citations
    26. Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm Clinical Pharmacokinetics · 2024 · 5 citations
    27. Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial American Journal of Clinical Dermatology · 2024 · 4 citations
    28. Estimation of health utility values for alopecia areata Quality of Life Research · 2024 · 4 citations
    29. Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment 2015 · 4 citations
    30. The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms Journal of Investigative Dermatology Symposium Proceedings · 2020 · 3 citations